Advisory Committee on Immunization Practices |
|
| FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION |
|
ACIP Recommendations: Topics of interest |
|
|
| |
|
|
Recommendations - Adolescents |
|
|
|
Prevention and Control of
Meningococcal Disease: Recommendations of the Advisory
Committee on Immunization Practices (ACIP)
Source: MMWR, March 22,
2013; 62(RR02):1-22 |
|
|
HTML | PDF |
ACIP Provisional
Recommendations Prevention of Measles, Rubella, Congenital
Rubella Syndrome (CRS), and Mumps
Source: Centers for Disease Control and Prevention, December
6, 2012 |
|
|
HTML | PDF |
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13
Influenza Season
Source: MMWR, August 18, 2012;61(32);613-8 |
|
|
HTML | PDF |
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8 |
|
| HTML | PDF |
Updated Recommendations
for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular
Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or
Anticipate Having Close Contact with an Infant Aged <12 Months --
Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426 |
|
|
HTML | PDF |
Licensure of a Meningococcal
Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated
Booster Dose Guidance for Adolescents and Other Persons at
Increased Risk for Meningococcal Disease — Advisory Committee on
Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011;
60(30):1018-1019 |
|
|
HTML | PDF |
General Recommendations on
Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60 |
|
|
HTML | PDF |
|
|
Updated Recommendations
for Use of Meningococcal Conjugate Vaccines--Advisory Committee on
Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011; 60(03):72-76 |
|
|
HTML | PDF |
|
|
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
(Tdap) Vaccine from the Advisory Committee on Immunization
Practices, 2010
Source: MMWR, January 14, 2011;
60(01):13-15 |
|
|
HTML | PDF |
|
|
FDA Licensure of Bivalent
Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and
Updated HPV Vaccination Recommendations from the Advisory Committee on
Immunization Practices (ACIP)
Source: MMWR, May 28, 2010;
59(20):626-629 |
|
| HTML | PDF |
|
|
FDA Licensure of
Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in
Males and Guidance from the Advisory Committee on Immunization
Practices (ACIP) Weekly
Source: MMWR, May 28, 2010;
59(20):630-632 |
|
| HTML | PDF |
|
|
| Licensure of a Meningococcal
Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on
Immunization Practices (ACIP), 2010 |
|
| HTML | PDF |
|
|
Revised Recommendations
of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal
Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795 |
|
| HTML | PDF |
|
|
Quadrivalent
Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24 |
|
| HTML | PDF |
|
|
Use of Tetanus Toxoid,
Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among
Adolescents
Please note: If you are using the HTML version of this document, be
sure to access all the HTML links to get the complete content of the document,
which includes important appendices.
Source:
MMWR, March 24, 2006, Vol. 55(RR03):1-49 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | HTML
pt.5 | HTML
pt.6 | HTML
pt.7 | PDF
(entire issue) |
| # |
|
|
|
|
Persons Vaccinated Outside the United States, Including Internationally Adopted Children
Source: See pp. 33-34, Table 12, General Recommendations on Immunization MMWR, December 1, 2006; 51(RR-2):1-48 |
|
| HTML | PDF |
| # |
|
|
|
|
Prevention and Control of
Meningococcal Disease: Recommendations of the Advisory
Committee on Immunization Practices (ACIP)
Source: MMWR, March 22,
2013; 62(RR02):1-22 |
|
|
HTML | PDF |
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13
Influenza Season
Source: MMWR, August 18, 2012;61(32);613-8 |
|
|
HTML | PDF |
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR, June 1, 2012; 61(21):394-5 |
|
|
HTML | PDF |
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8 |
|
| HTML | PDF |
General Recommendations on
Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60 |
|
|
HTML | PDF |
|
|
|
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
(Tdap) Vaccine from the Advisory Committee on Immunization
Practices, 2010
Source:: MMWR, January 14,
2011; 60(01):13-15 |
|
|
HTML | PDF |
|
|
Updated ACIP
Recommendations: Prevention of Invasive Pneumococcal Disease Among
Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine
(PPSV23)
Source: MMWR, September 3, 2010; 59(34):1102-6 |
|
| HTML | PDF |
|
|
Licensure of a High-Dose
Inactivated Influenza Vaccine for Persons Aged >=65 Years (Fluzone
High-Dose) and Guidance for Use--United States, 2010
Source: MMWR, April 30, 2010; 59(16):485-486 |
|
| HTML | PDF |
|
|
Recommended Adult
Immunization Schedule--United States, 2010
Source: MMWR, January 15, 2010;
59(01:1-4) |
|
| HTML | PDF |
|
|
Prevention of Herpes Zoster:
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 6, 2008; 57(05):1-30 |
|
| HTML | PDF |
|
|
Quadrivalent
Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24 |
|
| HTML | PDF |
|
|
Preventing Tetanus,
Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced
Diphtheria Toxoid and Acellular Pertussis Vaccine
Please note: If you are using the HTML version of this
document, be sure to access all four HTML links to get the complete content
of the document,
which includes 3 important appendices.
Source:
MMWR, December 15, 2006;55(RR-17):1-33 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
|
|
A Comprehensive Immunization
Strategy to Eliminate Transmission of Hepatitis B Virus Infection
in the United States. Part II: Immunization of Adults
Please note: If you are using the HTML
version of this document, be sure to access all four HTML links to get
the complete content of the document, which includes 3 important appendices.
Source:
MMWR, December 8, 2006;55(RR-16):1-25R |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
|
|
Using Live, Attenuated Influenza Vaccine
for Prevention and Control of Influenza
Source: MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB) |
|
| HTML | PDF |
|
|
Prevention of
Pneumococcal Disease
Source: MMWR April 04, 1997 / Vol. 46 / No. RR-08 |
|
| HTML | PDF |
|
|
Update on Adult
Immunization
Source: MMWR November 15, 1991 / Vol. 40 / No. RR-120 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Biopreparedness |
|
|
|
Use of Anthrax Vaccine in
the United States: Recommendations of the Advisory Committee on
Immunization Practices (ACIP), 2009
Source: MMWR, July 23, 2010;
59(rr06):1-36 |
|
| HTML | PDF |
|
|
Recommendations for Using Smallpox
Vaccine in a Pre-Event Vaccination Program
Source: MMWR, Recommendations and Reports, April 4, 2003, Vol. 52(RR-7) |
|
| HTML | PDF |
|
|
Use of Anthrax Vaccine in Response
to Terrorism
Source: MMWR, November 15, 2002, Vol. 51(45):1024-1026 |
|
| HTML | PDF |
|
|
Vaccinia (Smallpox)
Vaccine
Source: MMWR June 22, 2001 / Vol. 50 / No. RR-10 |
|
| HTML | PDF |
|
|
Use of Anthrax
Vaccine in the United States
Source: MMWR December 15, 2000 / Vol. 49 / No. RR-15 |
|
| HTML | PDF |
|
|
|
Prevention of
Plague
Source: MMWR December 13, 1996 / Vol. 45 / No. RR-14 |
|
| HTML | PDF |
| # |
|
|
|
|
Prevention and Control of
Meningococcal Disease: Recommendations of the Advisory
Committee on Immunization Practices (ACIP)
Source: MMWR, March 22,
2013; 62(RR02):1-22 |
|
|
HTML | PDF |
Infant Meningococcal
Vaccination: Advisory Committee on Immunization Practices
(ACIP) Recommendations and Rationale
Source: MMWR, January 25,
2013; 62(3):52-4 |
|
|
HTML | PDF |
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13
Influenza Season
Source: MMWR, August 18, 2012;61(32);613-8 |
|
|
HTML | PDF |
Recommendation of the
Advisory Committee on Immunization Practices (ACIP) for Use of
Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among
Children Aged 9 Through 23 Months at Increased Risk for Invasive
Meningococcal Disease
Source: MMWR, October 14, 2011; 60(40):1391-2 |
|
|
HTML | PDF |
Licensure of a Meningococcal
Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated
Booster Dose Guidance for Adolescents and Other Persons at
Increased Risk for Meningococcal Disease — Advisory Committee on
Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011;
60(30):1018-1019 |
|
|
HTML | PDF |
|
|
General Recommendations on
Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60 |
|
|
HTML | PDF |
|
|
|
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
(Tdap) Vaccine from the Advisory Committee on Immunization
Practices, 2010
Source: MMWR, January 14, 2011;
60(01):13-15 |
|
|
HTML | PDF |
|
|
|
Prevention of
Pneumococcal Disease Among Infants and Children--Use of 13-Valent
Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal
Polysaccharide Vaccine
Source: MMWR, December 10,
2010; 59(RR11):1-18 |
|
|
HTML | PDF |
|
|
Update: Recommendations of
the Advisory Committee on Immunization Practices (ACIP) Regarding Use
of CSL Seasonal Influenza Vaccine (Afluria) in the United States
During 2010-11
Source: MMWR, August 13, 2010;
59(31):989-92 |
|
| HTML | PDF |
|
|
Use of Combination Measles,
Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory
Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16 |
|
| HTML | PDF |
|
|
Licensure of a 13-Valent
Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use
Among Children --- Advisory Committee on Immunization Practices
(ACIP), 2010
Source: MMWR, March 12, 2010;
59(09):258-261 |
|
| HTML | PDF |
|
|
Licensure of a Haemophilus
influenzae Type b (Hib) Vaccine (Hiberix) and Updated Recommendations
for Use of Hib Vaccine
Source: MMWR September 18, 2009;
58(36):1008-1009 |
|
| HTML | PDF |
|
|
Prevention of Rotavirus Gastroenteritis
Among Infants and Children: Recommendations of the Advisory Committee on
Immunization Practices
Source: MMWR, February 6, 2009, Vol. 58
(RR-2) |
|
| HTML | PDF |
|
|
Updated Recommendation from the
Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent
Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who
Are Not Completely Vaccinated
Source: MMWR, April 4, 2008; 57(13):343-344 |
|
|
HTML | PDF |
Notice to Readers: Recommendation
from the Advisory Committee on Immunization Practices (ACIP) for
Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children
Aged 2--10 Years at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, December
7, 2007; 56(48):1265-1266 |
|
| HTML | PDF |
Expansion of Use of Live Attenuated
Influenza Vaccine (FluMist) to Children Aged 2-4 Years and Other
FluMist Changes for the 2007--08 Influenza Season
Source: MMWR, November
23, 2007; 56(46):1217-1219 |
|
| HTML | PDF |
Revised Recommendations
of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal
Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795 |
|
| HTML | PDF |
Prevention of
Varicella
Source: MMWR, June 22, 2007; 56(RR-4):1-40 |
|
| HTML | PDF |
Quadrivalent
Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24 |
|
| HTML | PDF |
Control and Elimination
of Mumps
Source: MMWR, June 9, 2006, Vol. 55(22):629-630 |
|
| HTML | PDF |
Prevention and Control of Meningococcal
Disease
Source: MMWR, May 27, 2005, Vol. 54(RR07):1-21 |
|
| HTML | PDF |
Using Live, Attenuated Influenza Vaccine
for Prevention and Control of Influenza
Source: MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB) |
|
| HTML | PDF |
Use of Diphtheria
Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose
Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13 |
|
| HTML | PDF |
Preventing
Pneumococcal Disease Among Infants and Young Children
Source: MMWR
October 6, 2000 / Vol. 49 / No. RR-09 |
|
| HTML | PDF |
Prevention
and Control of Meningococcal Disease
Source:MMWR
June 30, 2000 / Vol. 49 / No. RR-07 |
|
| HTML | PDF |
Poliomyelitis
Prevention in the United States
Source: MMWR May 19, 2000 / Vol. 49 / No. RR-05 |
|
| HTML | PDF |
Use of Haemophilus
b Conjugate Vaccines and a Combined DTP and Hib Vaccine
Source: MMWR September 17, 1993 / Vol. 42 / No. RR-13 |
|
| HTML | PDF |
Diphtheria,
Tetanus, and Pertussis, Recommendations for Vaccine Use and Other
Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10 |
|
| HTML | PDF |
Haemophilus
b Conjugate Vaccines for Prevention of Hib Disease
Source: MMWR January 11, 1991 / Vol. 40 / No. RR-01 |
|
| HTML | PDF |
Use of Combination Measles,
Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory
Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16 |
|
| HTML | PDF |
Combination
Vaccines for Childhood Immunization
Source: MMWR May 14, 1999 / Vol. 48 / No. RR-05 |
|
| HTML | PDF |
Use of Haemophilus
b Conjugate Vaccines and a Combined DTP and Hib Vaccine
Source: MMWR September 17, 1993 / Vol. 42 / No. RR-13 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Dialysis |
|
|
|
Guidelines for
Vaccinating Kidney Dialysis Patients and Patients with Chronic
Kidney Disease
Source: Centers for Disease Control and Prevention, June 2006 |
|
| HTML | PDF |
Recommendations
for Preventing Transmission of Infections Among Chronic Hemodialysis
Patients
(not an ACIP statement but an important update document)
Source: MMWR, April 27, 2001 / Vol. 50 / No. RR-5 |
|
| HTML | PDF |
Updated CDC Recommendations
for the Management of Hepatitis B Virus–Infected Health-Care
Providers and Students
(Not an ACIP statement
but an important document from CDC.)
Source: MMWR, July 6,
2012; 61(RR03):1-12 |
|
|
HTML | PDF |
Immunization of
Health-Care Personnel: Recommendations of the Advisory Committee
on Immunization Practices (ACIP)
Source: MMWR, November 25, 2011; 60(RR07):1-45 |
|
|
HTML | PDF |
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
(Tdap) Vaccine from the Advisory Committee on Immunization
Practices, 2010
Source: MMWR, January 14,
2011; 60(01):13-15 |
|
|
HTML | PDF |
| |
| ACIP Provisional
Recommendations for Measles-Mumps-Rubella (MMR) 'Evidence of Immunity'
Requirements for Healthcare Personnel, August 28, 2009 |
|
| HTML | PDF |
| |
Use of Influenza A (H1N1)
2009 Monovalent Vaccine
Source: MMWR, August 28, 2009;
58(RR10):1-8 |
|
| HTML | PDF |
|
Influenza Vaccination
of Health-Care Personnel
Source: MMWR, February 24, 2006, Vol. 55(RR02):1-16 |
|
| HTML | PDF |
Management of
Occupational Exposures to HBV, HCV, and HIV and Recommendations
for Postexposure Prophylaxis
(not an ACIP statement but an important update document)
Source: MMWR June 29, 2001 / Vol. 50 / No. RR-11 |
|
| HTML | PDF |
| # |
|
|
|
Recommendations - HepB Birth Dose |
|
|
|
A
Comprehensive Immunization Strategy to Eliminate Transmission of
Hepatitis B Virus Infection in the United States. Recommendations of the
Advisory Committee on Immunization Practices (ACIP). Part 1: Immunization
of Infants, Children and Adolescents.
Source: MMWR,
December 23, 2005, Vol. 54(RR-16):1-39 |
|
| HTML PT.1 | HTML
PT.2 | HTML
PT.3 | HTML
PT.4 | PDF |
|
|
Dear
Colleague Letter: Universal Infant Hepatitis B Vaccination Should Begin
At Birth, January 18, 2006
Authors:
Lance Rodewald and John Ward
Source: Centers for Disease Control and Prevention |
|
| HTML
| PDF |
| # |
|
|
|
|
ACIP Provisional
Recommendations Prevention of Measles, Rubella, Congenital
Rubella Syndrome (CRS), and Mumps
Source: Centers for Disease Control and Prevention, December
6, 2012 |
|
|
HTML | PDF |
Guidelines for the Prevention
and Treatment of Opportunistic Infections Among HIV-Exposed and
HIV-Infected Children: Recommendations from CDC, the National
Institutes of Health, the HIV Medicine Association of the Infectious
Diseases Society of America, the Pediatric Infectious Diseases
Society, and the American Academy of Pediatrics
(Not an ACIP statement, but an
important new recommendation from CDC.)
Source: MMWR, September 4, 2009; 58(RR11):1-166 |
|
| HTML | PDF |
|
|
CDC Guidelines: Revised
Recommendations for HIV Testing of Adults, Adolescents, and Pregnant
Women in Health-Care Setting
(Not an ACIP statement, but an important new recommendation from CDC)
Source: MMWR, September 22, 2006, Vol. 55(RR14):1-17 |
|
| HTML | PDF |
Management of
Occupational Exposures to HBV, HCV, and HIV and Recommendations
for Postexposure Prophylaxis
(not an ACIP statement but an important update document)
Source: MMWR June 29, 2001 / Vol. 50 / No. RR-11 |
|
| HTML | PDF |
Recommendations
for Preventing Transmission of Human Immunodeficiency Virus and
Hepatitis B Virus to Patients During Exposure-Prone Invasive Procedures
(not an ACIP statement but an important document)
Source: MMWR, July 12, 1991 / Vol. 40 / No. RR08 |
|
| HTML |
| # |
|
|
Recommendations - Long-Term Care |
|
|
|
Updated ACIP
Recommendations: Prevention of Invasive Pneumococcal Disease Among
Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine
(PPSV23)
Source: MMWR, September 3, 2010; 59(34):1102-6 |
|
| HTML | PDF |
|
|
Prevention of Pneumococcal Disease
Authors: Lance Rodewald and John Ward
Source: Centers for Disease Control and Prevention |
|
| HTML | PDF |
|
|
Notice to Readers: Facilitating Influenza and Pneumococcal Vaccination Through Standing Orders Programs
Author: Centers for Disease Control and Prevention
Source: MMWR, January 31, 2003, Vol. 52(04):68-9 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Men Who Have Sex With Men |
|
|
|
ACIP Recommendations Update: Prevention of Hepatitis A after Exposure to Hepatitis A Virus and in International Travelers
Source: MMWR, October 19, 2007; 56(41):1080-1084 |
|
| HTML | PDF |
|
|
ACIP Recommendations: A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part II: Immunization of Adults
Source: MMWR, December 8, 2006;55(RR-16):1-25 |
|
| HTML PT.1 | HTML PT.2 | HTML PT.3 | HTML PT.4 | PDF |
|
|
Prevention of Hepatitis A Through Active or Passive Immunization
Source: MMWR, May 19, 2006, Vol. 55(RR07):1-23 |
|
| HTML | PDF |
|
|
Sexually Transmitted Diseases Treatment Guidelines, 2006
Source: MMWR, August 4, 2006, Vol. 55(RR11):1-94 |
|
| HTML | PDF |
|
|
CDC Dear Colleague Letter on Recommended Sexually Transmitted Diseases (STD) Prevention Services for Men Who Have Sex With Men (MSM)
Source: CDC's Division Viral Hepatitis, Division of Sexually Transmitted Diseases, Division of Immunization Services, and Division of HIV/AIDS Prevention. |
|
| HTML | PDF |
| # |
|
|
|
|
Use of a Reduced (4-Dose)
Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies
Source: MMWR, March 19, 2010;
59(02):1-9 |
|
| HTML | PDF |
|
|
Update: Prevention of Hepatitis A after
Exposure to Hepatitis A Virus and in International Travelers
Source: MMWR,
October 19, 2007; 56(41):1080-1084 |
|
| HTML | PDF |
Investigational Product
(VariZIG) for Postexposure Prophylaxis of Varicella
Source: MMWR, February 24, 2006, Vol. 55:1-2 |
|
| HTML | PDF |
Postexposure Prophylaxis/Pertussis/CDC
Treatment Guidelines: Recommended Antimicrobial Agents for the Treatment
and Postexposure Prophylaxis of Pertussis
(not an ACIP statement but a recommendation from NIP, CDC)
Source: MMWR, December 9, 2005, Vol. 54(RR14):1-16 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Pregnancy |
|
|
|
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee
on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5 |
|
|
HTML | PDF |
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine
in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70 |
|
|
HTML | PDF |
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
(Tdap) Vaccine from the Advisory Committee on Immunization
Practices, 2010
Source:: MMWR, January 14,
2011; 60(01):13-15 |
|
|
HTML | PDF |
|
|
Prevention of Pertussis, Tetanus, and
Diphtheria Among Pregnant and Postpartum Women and Their Infants:
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 30, 2008; 57
(04):1-47,51 |
|
|
HTML pt 1 |
HTML pt 2 |
HTML pt 3 |
PDF |
ACIP: Guidance for Vaccine
Recommendations in Pregnant and Breastfeeding Women
Source: Centers for Disease Control and Prevention, April 2008 |
|
| HTML | PDF |
Guidelines for
Vaccinating Pregnant Women: Recommendations of the Advisory Committee on
Immunization Practices (ACIP)
Source: Centers
for Disease Control and Prevention, Updated May 2007 |
|
|
HTML | PDF |
CDC Guidelines:
Evaluation and Management of Suspected Outbreaks, Rubella in Pregnant
Women, and Surveillance for Congenital Rubella Syndrome
(not an ACIP statement but an important update document)
Source: MMWR July 13, 2001 / Vol. 50 / No. RR-12 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Registries |
|
|
|
CDC Guidelines:
Development of Community- and State-Based Immunization Registries
(not an ACIP statement but an important document)
Source: MMWR October 5, 2001 / Vol 50 / No. RR-17 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Schedules |
|
|
|
Advisory Committee on
Immunization Practices (ACIP) Recommended Immunization
Schedules for Persons Aged 0 Through 18 years and Adults
Aged 19 Years and Older — United States, 2013
Source: MMWR Supplements, February 1, 2013; 62(01):1-21 |
|
|
HTML | PDF |
ACIP Provisional
Recommendations Prevention of Measles, Rubella, Congenital
Rubella Syndrome (CRS), and Mumps
Source: Centers for Disease Control and Prevention, December
6, 2012 |
|
|
HTML | PDF |
Recommendations for Use of a
Booster Dose of Inactivated Vero Cell Culture-Derived Japanese
Encephalitis Vaccine -- Advisory Committee on Immunization
Practices, 2011
Source: MMWR, May 27, 2011;
60(20):661-3 |
|
|
HTML | PDF |
Update on Japanese Encephalitis
Vaccine for Children
Source: MMWR, May 27, 2011; 60(20):664-5 |
|
|
HTML | PDF |
Yellow Fever Vaccine:
Recommendations of the Advisory Committee on Immunization Practices
(ACIP)
Source: MMWR, July 30, 2010;
59(RR07):1-27 |
|
| HTML | PDF |
|
|
Japanese Encephalitis
Vaccines
Source: MMWR, March 12, 2010;
59(01):1-27 |
|
| HTML | PDF |
Human Rabies Prevention--United
States, 2008: Recommendations of the Advisory Committee on Immunization
Practices
Source: MMWR, May 23, 2008; 57(RR03):1-26,28 |
|
|
HTML pt 1 |
HTML pt 2 | PDF |
Update: Prevention of Hepatitis A after
Exposure to Hepatitis A Virus and in International Travelers
Source: MMWR,
October 19, 2007; 56(41):1080-1084 |
|
| HTML | PDF |
A Comprehensive Immunization
Strategy to Eliminate Transmission of Hepatitis B Virus Infection
in the United States. Part II: Immunization of Adults
Please note: If you are using the HTML
version of this document, be sure to access all four HTML links to get
the complete content of the document, which includes 3 important appendices.
Source:
MMWR, December 8, 2006;55(RR-16):1-25R |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
Prevention of Hepatitis
A Through Active or Passive Immunization
Source: MMWR, May 19, 2006, Vol. 55(RR07):1-23 |
|
| HTML | PDF |
Yellow Fever Vaccine
Source: MMWR, November 8, 2002, Vol. 51/RR17 |
|
| HTML | PDF |
Typhoid Immunization
Source: MMWR December 9, 1994/ Vol. 43/ No. RR-14 |
|
| HTML | PDF |
|
| This
page was reviewed on
April 9, 2013 |
|
 |
|
|
|
|
|
Immunization Action Coalition • 1573 Selby Ave • St. Paul, MN 55104 |
|
tel 651-647-9009 • fax 651-647-9131 |
|
|
| |
|
|
|
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC. |
|
|
| |
| |
|
|
A-Z
IAC Home